Wikidata

(Q54372714)

English

Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.

scientific article published on 16 May 2011

In more languages

Statements

title
Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21576633
retrieved
28 May 2018
reference URL
http://europepmc.org/abstract/MED/21576633
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q54372714&oldid=1776819962"